⌘K

Home/Filings/4/0001140361-25-014262

4//SEC Filing

D'Andrea Carrie 4

Accession 0001140361-25-014262

CIK 0001444192other

View on SEC.gov Company Profile

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 8:58 PM ET

Size

18.7 KB

Accession

0001140361-25-014262

Insider Transaction Report

Form 4

Period: 2025-04-14

Grace Therapeutics, Inc.GRCE

D'Andrea Carrie

VP Clinical Operations

Transactions

Award
Stock Option (Right to Buy)
2025-04-14+30,000→ 30,000 total
Exercise: $2.08Exp: 2035-04-14→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date.

Documents

2 files

Issuer

Grace Therapeutics, Inc.

CIK 0001444192

Entity typeother

Related Parties

1

filerCIK 0001977969

Filing Metadata

Form type: 4
Filed: Apr 15, 8:00 PM ET
Accepted: Apr 16, 8:58 PM ET
Size: 18.7 KB

View on SEC.gov